Evaluation of the weight-increasing effects of biphasic analog and regular NPH insulin mixtures in patients with Type 2 diabetes mellitus

Journal of Diabetes

Volumn 2, Issue 4, 2010, Pages 250-255

  Temizel, Mustafa ^a   Mert, Meral ^b   Bozbey, Celal ^a   Arman, Yücel ^a   Cevizci, Ertan ^a   Altintaş, Nejat ^a   Çetin Ölek, Ali ^a  

^a OKMEYDANI TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b Kayseri Training and Research Hospital   (Turkey)

Author keywords

insulin; Type 2 diabetes mellitus; weight gain

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN ASPART; INSULIN LISPRO; ISOPHANE INSULIN; METFORMIN;

ADULT; ARTICLE; BODY MASS; BODY WEIGHT; DIET THERAPY; DRUG EFFECT; DRUG MECHANISM; DRUG MIXTURE; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SIDE EFFECT; TREATMENT DURATION; WEIGHT GAIN;

AGED; BLOOD GLUCOSE; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN, NPH; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; WEIGHT GAIN;

EID: 78649645191     PISSN: 17530393     EISSN: 17530407     Source Type: Journal    
DOI: 10.1111/j.1753-0407.2010.00080.x     Document Type: Article

References (21)

1. Kahn CR, Weir GC, King GL, Jacobson AM, Moses AC, Smith RJ,. Joslin's Diabetes Mellitus, 14th edn. Lippincott Willams-Wilkins, Boston, 2005.
2. Wild S, Roglic G, Green A, Sicree R, King H,. Global prevalence of diabetes estimates for the year 2000 and projections for 2030. Diabetes Care. 2004; 27: 1047-53.
3. Khan R,. Weight gain and insulin therapy. Br J Diabetes Vasc Dis. 2004; 4: 264-7.
4. Heller S,. Weight gain during insulin therapy in patients with Type 2 diabetes mellitus. Diabetes Res Clin Pract. 2004; 65 (Suppl. 1): 23-7.
5. Russell-Jones D, Khan R,. Insulin-associated weight gain in diabetes: causes, effects and coping strategies. Diabetes Obes Metab. 2007; 9: 799-812.
6. Carver C,. Insulin treatment and the problem of weight gain in Type 2 diabetes. Diabetes Educ. 2006; 32: 910-7.
7. Garber AJ, Ligthelm RC, Christiansen Jens S, Liebl A,. Premixed insulin treatment for type 2 diabetes: analog or human? Diabetes Obes Metab. 2007; 9: 360-639.
8. Başkal N,. Endokrinolojide Diyalog Diyabet Tedavisinde Yeni Açilimlar [New paradigm for the treatment of diabetes]. Endokrinolojide Diyalog. 2007; 4: 215-22.
9. UK Prospective Diabetes Study (UKPDS) Group. UKPDS: intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with Type 2 diabetes (UKPDS33). Lancet. 1998; 352: 837-53.
10. The Diabetes Control and Complications Trial Research Group. DCCT: the effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993; 329: 977-86.
11. Aas A-M, Ohrvik J, Malmberg K, Ryden L, Birkeland KI, for the DIGAMI 2 Investigators. Insulin-induced weight gain and cardiovascular events in patients with Type 2 diabetes. A report from the DIGAMI 2 study. Diabetes Obes Metab. 2009; 11: 323-9.
12. Gough SCL, Tibaldi J,. Biphasic insulin aspart in Type 2 diabetes mellitus: an evidence-based medicine review. Clin Drug Investig. 2007; 27: 299-324.
13. Yang W, Ji Q, Zhu D, et al. Biphasic insulin aspart 30 three times daily is more effective than a twice-daily regimen, without increasing hypoglycemia, in Chinese subjects with Type 2 diabetes inadequately controlled on oral antidiabetes drugs. Diabetes Care. 2008; 31: 852-6.
14. Jang HC, Lee SR, Vaz JA,. Biphasic insulin aspart 30 in the treatment of elderly patients with Type 2 diabetes: a subgroup analysis of the PRESENT Korea NovoMix(R) study. Diabetes Obes Metab. 2009; 11: 20-6.
15. Makimattila S, Nikkila K, Yki-Jarvinen H,. Causes of weight gain during insulin therapy with and without metformin in patients with non-insulin- dependent diabetes. Diabetologia. 1999; 42: 406-12.
16. Malone JK, Kerr LF, Campaigne BN, Sachson RA, Holcombe JH,. Combined therapy with insulin lispro mix 75/25 plus metformin or insulin glargine plus metformin: a 16-week, randomized, open-label, crossover study in patients with Type 2 diabetes beginning insulin therapy. Clin Ther. 2004; 26: 2034-44.
17. Salle A, Ryan M, Guilloteau G, Bouhanick B, Berrut G, Ritz P,. Glucose control-related and non-glucose control-related effects of insulin on weight gain in newly insulin-treated Type 2 diabetic patients. Br J Nutr. 2005; 94: 931-7.
18. Holman RR, Thorne KI, Farmer AJ, et al. Addition of biphasic, prandial, or basal insulin to oral therapy in Type 2 diabetes. N Engl J Med. 2007; 357: 1716-30.
19. Bode BW, Sabah HT, Gross TM, et al. Diabetes management in the new millennium using insulin pump therapy. Diabetes Metab Res Rev. 2002; 18: 14-20.
20. Pouwels JJ, Tack CJ, Hermust AR, et al. Tretment with intravenous insulin followed by continous subcutaneous insulin infusion improves glycaemic control in severely resistant Type 2 diabetic patients. Diabet Med. 2003; 20: 76-9.
21. Lingvay I, Legendre JL, Kaloyanova PF, Zhang S, Adams-Huet B, Raskin P,. Insulin-based versus triple oral therapy for newly diagnosed Type 2 diabetes: which is better? Diabetes Care. 2009; 32: 1789-95.